The University of Chicago Header Logo

Connection

Nina Paleologos to ErbB Receptors

This is a "connection" page, showing publications Nina Paleologos has written about ErbB Receptors.
Connection Strength

0.026
  1. A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. Neuro Oncol. 2015 Jun; 17(6):854-61.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.